These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payment of Filing Fee (Check the appropriate box):
|
||
|
☒
|
No fee required.
|
|
|
☐
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
|
(1)
|
Title of each class of securities to which transaction applies:
|
|
|
(2)
|
Aggregate number of securities to which transaction applies:
|
|
|
(3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
(4)
|
Proposed maximum aggregate value of transaction:
|
|
|
(5)
|
Total fee paid:
|
|
|
☐
|
Fee paid previously with preliminary materials.
|
|
|
☐
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of its filing.
|
|
|
(1)
|
Amount Previously Paid:
|
|
|
(2)
|
Form, Schedule or Registration Statement No.:
|
|
|
(3)
|
Filing Party:
|
|
|
(4)
|
Date Filed:
|
|
|
4
|
||
|
4
|
||
|
5
|
||
|
5
|
||
|
5
|
||
|
6
|
||
|
6
|
||
|
7
|
||
|
10
|
||
|
11
|
||
|
11
|
||
|
15
|
||
|
15
|
||
|
16
|
||
|
17
|
||
|
19
|
||
|
19
|
||
|
26
|
||
|
27
|
||
|
29
|
||
|
31
|
||
|
33
|
||
|
37
|
||
|
38
|
||
|
39
|
||
|
40
|
||
|
40
|
||
|
40
|
||
|
40
|
||
|
41
|
||
|
Name
|
Class
|
Age
|
Position
|
Elected Director (Calendar Year)
|
Current Term Expires
(Calendar Year)
|
Expiration of Term for which Nominated
(Calendar Year)
|
||||||||||
|
Director Nominees
|
||||||||||||||||
|
Avery More
(1)(3)
|
III
|
63
|
Director
|
2006
|
2018
|
2021
|
||||||||||
|
Guy Sella
|
III
|
54
|
Chief Executive Officer and Chairman of the Board
|
2006
|
2018
|
2021
|
||||||||||
|
Continuing Directors
|
||||||||||||||||
|
Dan Avida
(1)(3)
|
I
|
|
54
|
Director
|
2007
|
2019
|
||||||||||
|
Yoni Cheifetz
(3)
|
I
|
57
|
Director
|
2010
|
2019
|
|||||||||||
|
Doron Inbar
(1)(2)
|
I
|
68
|
Director
|
2010
|
2019
|
|||||||||||
|
Marcel Gani
(1)(2)
|
II
|
65
|
Director
|
2015
|
2020
|
|||||||||||
|
Tal Payne
(2)
|
II
|
46
|
Director
|
2015
|
2020
|
|||||||||||
| (1) |
Member of the Compensation Committee.
|
| (2) |
Member of the Audit Committee.
|
| (3) |
Member of the Nominating and Corporate Governance Committee.
|
|
The Board of Directors recommends a vote FOR the election of each of the two director nominees.
|
| · |
appointing, compensating, retaining, evaluating, terminating and overseeing our outside auditor;
|
| · |
at least annually, reviewing the independence of our outside auditor;
|
| · |
reviewing with our independent registered public accounting firm the matters required to be reviewed by applicable auditing requirements;
|
| · |
approving in advance all audit and permissible non-audit services to be performed by our independent registered public accounting firm;
|
| · |
meeting to review and discuss with management and the outside auditor the annual audited and quarterly financial statements of the Company and the independent auditor’s reports related to the financial statements;
|
| · |
receiving reports from management regarding, and reviewing and discussing the adequacy and effectiveness of, the Company’s disclosure controls and procedures;
|
| · |
establishing and overseeing procedures for the confidential anonymous submission of concerns regarding questionable accounting, internal controls, auditing and federal securities law matters;
|
| · |
establishing and periodically reviewing policies and procedures for the review, approval, and ratification of related person transactions; and
|
| · |
overseeing the preparation of the report of the audit committee that SEC rules require to be included in our annual proxy statement.
|
| · |
overseeing our overall compensation philosophy, policies, and programs;
|
| · |
reviewing and approving corporate goals and objectives relevant to the compensation of our Chief Executive Officer, evaluating the Chief Executive Officer’s performance in light of those goals and objectives, approving grants of equity awards to the Chief Executive Officer and recommending to the independent directors the Chief Executive Officer’s compensation level based on this evaluation;
|
| · |
overseeing the evaluation of other executive officers and approving equity awards to these officers, and setting their compensation based upon the recommendation of the Chief Executive Officer;
|
| · |
reviewing and approving the design of other benefit plans pertaining to executive officers;
|
| · |
reviewing and approving employment agreements and other similar arrangements between us and our executive officers; and
|
| · |
overseeing preparation of the report of the Compensation Committee to the extent required by SEC rules to be included in our annual meeting proxy statement.
|
| · |
identifying individuals qualified to become members of our Board of Directors, consistent with criteria approved by our Board of Directors;
|
| · |
assessing the contributions and independence of incumbent directors in determining whether to recommend them for reelection to the Board;
|
| · |
developing and recommending to our Board of Directors a set of corporate governance guidelines and principles;
|
| · |
establishing procedures for the consideration of Board candidates recommended by the Company’s stockholders;
|
| · |
recommending to the Board candidates to be elected by the Board to fill vacancies and newly created directorships and candidates for election or reelection at each annual stockholders’ meeting;
|
| · |
periodically reviewing the Board’s leadership structure, size, composition, and functioning;
|
| · |
overseeing succession planning for positions held by executive offices;
|
| · |
overseeing the evaluation of the Board and its committees; and
|
| · |
annually reviewing the compensation of directors for service on the Board and its committees and recommend changes in compensation to the Board, as appropriate.
|
| · |
demonstrated business acumen and leadership, and high levels of accomplishment;
|
| · |
ability to exercise sound business judgment and to provide insight and practical wisdom based on experience;
|
| · |
commitment to understand the Company and its business, industry, and strategic objectives;
|
| · |
integrity and adherence to high personal ethics and values, consistent with our Code of Business Conduct and Ethics;
|
| · |
commitment to enhancing stockholder value;
|
| · |
willingness to act in the interest of all stockholders; and
|
| · |
for non-employee directors, independence under NASDAQ listing standards and other applicable rules and regulations.
|
|
Fiscal
2016
|
Six Months Ended
December 31, 2016
|
Calendar
2017
|
||||||||||
|
In thousands of Dollars
|
||||||||||||
|
Audit fees(1)
|
525
|
395
|
535
|
|||||||||
|
Tax fees(2)
|
27
|
26
|
97
|
|||||||||
|
Total audit and related fees
|
552
|
421
|
632
|
|||||||||
| (1) |
“Audit fees” are fees for audit services for each of the years shown in this table, including fees associated with the annual audit (including audit of our internal control over financial reporting in fiscal year 2016, for the six months ended December 31, 2016 and for the year ended December 31, 2017), reviews of our quarterly financial results submitted on Form 10-Q, and consultations on various accounting issues
.
|
| (2) |
Represents professional services rendered for tax compliance, tax advice, tax planning, and review of our Israeli tax returns.
|
|
The Board of Directors recommends a vote FOR the ratification
of the appointment of EY for 2018. |
|
The Board of Directors recommends a vote FOR the approval of our executive compensation on an advisory basis.
|
| · |
each person known to us to beneficially own 5% or more of the outstanding shares of our common stock;
|
| · |
each member of our Board of Directors and director nominees;
|
| · |
each of our named executive officers; and
|
| · |
the members of our Board of Directors and our executive officers as a group.
|
|
Shares Beneficially Owned
|
||||||||
|
Name of Beneficial Owner
|
Shares
|
%
|
||||||
|
5% Stockholders:
|
||||||||
|
BlackRock, Inc. (1)
|
3,155,082
|
7.1
|
%
|
|||||
|
Senvest Management, LLC(2)
|
2,644,057
|
5.9
|
%
|
|||||
|
Directors and Named Executive Officers:
|
||||||||
|
Guy Sella(3)
|
1,146,227
|
2.6
|
%
|
|||||
|
Ronen Faier(4)
|
96,990
|
*
|
||||||
|
Zvi Lando(5)
|
245,323
|
*
|
||||||
|
Yoav Galin(6)
|
348,657
|
*
|
||||||
|
Lior Handelsman(7)
|
275,723
|
*
|
||||||
|
Dan Avida(8)
|
841,235
|
1.9
|
%
|
|||||
|
Yoni Cheifetz(9)
|
41,993
|
*
|
||||||
|
Marcel Gani(10)
|
31,984
|
*
|
||||||
|
Doron Inbar(11)
|
174,207
|
*
|
||||||
|
Avery More(12)
|
615,137
|
1.4
|
%
|
|||||
|
Tal Payne (13)
|
20,874
|
*
|
||||||
|
All directors and executive officers as a group (13 individuals)(14)
|
4,330,102
|
9.7
|
%
|
|||||
| * |
Represents beneficial ownership of less than 1%.
|
| (1) |
Based solely on a Schedule 13G/A filed with the SEC by Blackrock Inc., on February 1, 2018. Schedule 13G/A contains information as of December 31, 2017. Blackrock Inc. reports having power to dispose or to direct the disposition of over all of the shares reported above. The address of the reporting persons is 55 East 52nd Street New York, NY 10055
|
| (2) |
Based solely on a Schedule 13G/A filed with the SEC by Senvest Management, LLC and Richard Mashaal, who is the managing member of Senvest Management, LLC, on February 13, 2017. Schedule 13G/A contains information as of December 31, 2016. Senvest Management, LLC and Richard Mashaal report having shared voting and shared dispositive power over all of the shares reported above. The address of the reporting persons is c/o Senvest Management, LLC is 540 Madison Avenue, 32nd Floor New York, New York 10022
|
| (3) |
Consists of 483,836 shares of common stock owned of record by Mr. Sella, and 662,391 shares of common stock issuable upon exercise of
options exercisable
within 60 days of March 22, 2018.
|
| (4) |
Consists of 18,085 shares of common stock owned of record by Mr. Faier and 78,905 shares of common stock issuable upon exercise of
options exercisable
within 60 days of March 22, 2018.
|
| (5) |
Consists of 18,085 shares of common stock owned of record by Mr. Lando and 227,238 shares of common stock issuable upon exercise of
options exercisable
within 60 days of March 22, 2018.
|
| (6) |
Consists of 315,585 shares of common stock owned of record by Mr. Galin and 33,072 shares of common stock issuable upon exercise of
options exercisable
within 60 days of March 22, 2018.
|
| (7) |
Consists of 50,542 shares of common stock owned of record by Mr. Handelsman and 225,181 shares of common stock issuable upon exercise of
options exercisable
within 60 days of March 22, 2018.
|
| (8) |
Consists of 13,008 shares of common stock owned of record by Mr. Avida, 7,866 shares of common stock issuable upon settlement of restricted stock units which will vest and settle within 60 days of March 22, 2018, 800,000 shares of common stock held by Opus Capital Venture Partners L.P.’s investment committee consists of Carl Showalter, Dan Avida, Gill Cogan and Joseph Cutts and 20,361 shares of common stock held by The Zarbu Revocable Trust, c/o Dan Avida.
|
| (9) |
Consists of 34,127 shares of common stock owned of record by Mr. Cheifetz and 7,866 shares of common stock issuable upon settlement of
restricted stock units
which will vest and settle within 60 days of March 22, 2018.
|
| (10) |
Consists of 13,008 shares of common stock owned of record by Mr. Gani, 7,866 shares of common stock issuable upon settlement of
restricted stock units
which will vest and settle within 60 days of March 22, 2018, 5,555 shares of common stock held directly by Marcel Gani 2002 Living Trust and 5,555 shares of common stock held directly by ALGA Partners LLC. Mr. Gani, in his capacity as trustee, has voting and investment power over the shares owned by the Marcel Gani 2002 Living Trust. Mr. Gani, in his capacity as manager, has voting and investment power over the shares owned by ALGA Partners LLC.
|
| (11) |
Consists of 13,008 shares of common stock owned of record by Mr. Inbar, 153,333 shares of common stock issuable upon exercise of
options exercisable
within 60 days of March 22, 2018, and 7,866 shares of common stock issuable upon settlement of restricted stock units which will vest and settle
within 60 days of March 22, 2018.
|
| (12) |
Consists of 122,080 shares of common stock owned of record by Mr. More, 7,866 shares of common stock issuable upon settlement of restricted stock units which will vest and settle within 60 days of March 22, 2018, 469,850 shares of common stock held by ORR Partners I GP, LP, a limited partnership controlled by Avery More and 15,341 shares held by Avery More's wife, Jerralyn Smith More, as to which Avery More disclaims any ownership interest.
|
| (13) |
Consists of 13,008 shares of common stock owned of record by Ms. Payne and 7,866 shares of common stock issuable upon settlement of
restricted stock units
which will vest and settle within 60 days of March 22, 2018.
|
| (14) |
Consists of 2,744,491 shares of common stock, 1,538,415 shares of common stock issuable upon exercise of
options
exercisable within 60 days of March 22, 2018, and 47,196 shares of common stock issuable upon settlement of restricted stock units which will vest and settle
within 60 days of March 22, 2018.
|
|
|
•
|
|
motivate our executives to maximize stockholder value;
|
|
|
•
|
|
provide compensation that varies based on performance; and
|
|
|
•
|
|
attract and retain managerial talent, without promoting unreasonable risk-taking.
|
|
|
•
|
|
robust selling restrictions;
|
|
|
•
|
|
restrictions on hedging and pledging the Company’s common stock;
|
|
|
•
|
|
use of objective, performance criteria in our short- and long-term incentive plans;
|
|
|
•
|
|
advice from independent compensation consultants retained by the Compensation Committee; and
|
|
|
•
|
|
no specific retirement benefit plans designed solely for senior executives or related entitlements such as executive benefits and perquisites, tax gross-ups, etc.
|
| · |
Guy Sella, our Chief Executive Officer and Chairman of the Board;
|
| · |
Ronen Faier, our Chief Financial Officer;
|
| · |
Zvi Lando, our Vice President, Global Sales;
|
| · |
Yoav Galin, our VP Research and Development; and
|
| · |
Lior Handelsman, our VP Marketing & Product Strategy.
|
|
|
•
|
|
Pay for Performance:
Motivate, recognize, and reward superior performance and individual contributions.
|
|
|
•
|
|
Alignment of Interests:
We seek to align the interests of our senior executives with those of our stockholders.
|
|
|
•
|
|
Attraction, Motivation, and Retention of Talent:
Our senior executive compensation programs are designed to help us attract, motivate, and retain key management talent who drive profitability and the creation of stockholder value.
|
|
Compensation Element
|
Form
|
Objective
|
Rationale / Key Characteristics
|
|
Base Salary
|
Cash
|
Attraction
Retention
Performance
|
• Fixed compensation
• Intended to be commensurate with each senior executive’s position and level of responsibility
• Evaluated annually or as necessary in response to organizational/business changes, individual performance, market data, etc., but not automatically increased
|
|
Annual Cash Incentive Compensation
|
Cash
|
Performance
Alignment of Interests
Motivation
|
• Tied to Company and, for all NEOs other than the CEO, individual performance
• Designed to reward achievement of annual performance goals that we consider important contributors to stockholder value
• Performance goals and targets are established by the Compensation Committee at the beginning of each calendar year
• The Compensation Committee approves annual cash incentive award payouts based on the level of achievement of these pre-established goals
|
|
Long-Term Incentives
|
Options
|
Performance
Alignment of Interests
Retention
Motivation
|
• As options have no value unless the value of our common stock increases, it aligns the interests of senior executives with those of our stockholders and motivates such executives to perform in a manner that is designed to increase the value of our common stock
• The multi-year vesting encourages retention as recipients need to remain employed in order for vesting to occur
|
|
Restricted Stock Units
|
Performance
Alignment of Interest
Retention
Motivation
|
• Variable compensation designed to reward contributions to our long-term strategic, financial, and operational success, motivate future performance, align the interests of senior executives with those of stockholders, and retain key senior executives through the term of the awards
|
|
|
Other Compensation and Benefits
|
N/A
|
Attraction
Retention
|
• NEOs receive benefits that are generally available to all salaried employees in Israel, where the NEOs are located. This includes contributions to an education fund and to a fund known as Manager’s Insurance, which provides a combination of retirement plan, insurance, and severance pay benefits to Israeli employees.
• NEOs receive benefits that we generally make available to all salaried employees, including participation in the Employee Stock Purchase Plan.
|
|
Change–in- Control Arrangements
|
Equity
|
Attraction
Retention
|
• Each of our NEOs has a clause in the NEO’s employment agreement that entitles the NEO to immediate vesting of equity in the event of a qualifying termination within one year following a change in control (“double-trigger” equity vesting)
• Keep management’s highest priority on stockholder interests in the face of events that may result in a change-in-control and not on potential individual implications of any such events
• Reasonable change-in-control protections for our senior executives are necessary in order for us to attract and retain qualified employees
• We periodically review the necessity and design of our senior executive severance and change-in-control arrangements
|
|
August 2016 and December 2017 Base Salary Decisions
|
|
|||||||||||||||||||
|
Name and Principal Position
|
Annual base salary prior to August 2016 ($)
|
Annual base salary after August 2016 increase ($)
|
Percentage increase
|
Annual base salary after December 2017 Compensation Review ($)(*)
|
Percentage change
|
|||||||||||||||
|
Guy Sella - Chief Executive Officer and Chairman of the Board
|
510,000
|
550,000
|
8
|
%
|
611,000
|
11
|
%
|
|||||||||||||
|
Ronen Faier - Chief Financial Officer
|
300,000
|
315,000
|
5
|
%
|
350,000
|
11
|
%
|
|||||||||||||
|
Zvi Lando - Vice President, Global Sales
|
300,000
|
315,000
|
5
|
%
|
350,000
|
11
|
%
|
|||||||||||||
|
Yoav Galin - VP Research and Development
|
275,000
|
290,000
|
5
|
%
|
322,000
|
11
|
%
|
|||||||||||||
|
Lior Handelsman - VP Marketing & Product Strategy
|
240,000
|
265,000
|
10
|
%
|
295,000
|
11
|
%
|
|||||||||||||
|
|
|
The Compensation Committee,
Avery More, Chairman
Dan Avida
Marcel Gani
Doron Inbar
|
| · |
the balance between annual and long-term compensation, including the fact that a significant portion of compensation is delivered in the form of equity incentives that vest over several years;
|
| · |
the use of multiple financial metrics for performance-based annual and long-term incentive awards and the use of individual goals under our annual cash incentive program;
|
| · |
the Compensation Committee’s ability to modify annual cash incentives to reflect the quality of earnings, individual performance, and other factors that it believes should influence compensation; and
|
| · |
our management stock-selling restrictions encourage a longer-term perspective and align the interests of senior executives and the Board, as applicable, with other stockholders.
|
|
Name and Principal Position
|
Year
|
Salary
($)(1) |
Bonus
($)(1) |
Option Awards ($)(3)
|
Stock Awards ($)(3)
|
Non-Equity Incentive Plan Compensation($)(1)(4)
|
All Other
Compensation ($)(1) |
Total
($) |
||||||||||||||||||||||
|
Guy Sella -
|
2017
|
600,221
|
—
|
1,002,437
|
986,343
|
645,219
|
94,261(5)
|
|
3,328,481
|
|||||||||||||||||||||
|
Chief Executive Officer and Chairman of the Board
|
2016SP
|
274,135
|
—
|
499,793
|
505,551
|
503,073
|
42,801(6)
|
1,825,353
|
||||||||||||||||||||||
|
2016
|
483,192
|
—
|
641,051
|
903,240
|
714,528
|
72,435(7)
|
|
2,814,446
|
||||||||||||||||||||||
|
2015
|
298,114
|
243,808(2)
|
|
4,650,956
|
—
|
174,348
|
46,749(8)
|
|
5,413,975
|
|||||||||||||||||||||
|
Ronen Faier -
|
2017
|
343,763
|
—
|
325,242
|
320,010
|
241,153
|
53,725(9)
|
|
1,283,893
|
|||||||||||||||||||||
|
Chief Financial Officer
|
2016SP
|
158,355
|
—
|
162,157
|
164,028
|
203,923
|
24,931(10)
|
|
713,395
|
|||||||||||||||||||||
|
2016
|
283,315
|
—
|
256,420
|
361,296
|
260,841
|
42,666(11)
|
|
1,204,538
|
||||||||||||||||||||||
|
2015
|
180,319
|
92,879(2)
|
|
154,399
|
—
|
59,574
|
28,720(12)
|
|
515,891
|
|||||||||||||||||||||
|
Zvi Lando -
|
2017
|
343,763
|
—
|
325,242
|
320,010
|
248,474
|
56,302(13)
|
|
1,293,791
|
|||||||||||||||||||||
|
Vice President, Global Sales
|
2016SP
|
158,355
|
—
|
162,157
|
164,028
|
195,864
|
25,932(14)
|
|
706,337
|
|||||||||||||||||||||
|
2016
|
288,503
|
—
|
256,420
|
361,296
|
247,065
|
46,329(15)
|
|
1,199,614
|
||||||||||||||||||||||
|
2015
|
190,260
|
—
|
154,399
|
—
|
71,815
|
31,688(16)
|
|
448,162
|
||||||||||||||||||||||
|
Yoav Galin -
VP Research and Development
|
2017
|
316,480
|
—
|
325,242
|
320,010
|
209,731
|
52,195(17)
|
|
1,223,658
|
|||||||||||||||||||||
|
2016SP
|
145,584
|
—
|
162,157
|
164,028
|
178,415
|
24,220(18)
|
|
674,405
|
||||||||||||||||||||||
|
2016
|
262,299
|
—
|
256,420
|
361,296
|
235,933
|
42,256(19)
|
|
1,158,204
|
||||||||||||||||||||||
|
Lior Handelsman -
|
2017
|
289,198
|
—
|
189,460
|
186,419
|
190,368
|
46,305(20)
|
|
901,750
|
|||||||||||||||||||||
|
VP Marketing & Product Strategy
|
2016SP
|
131,106
|
—
|
94,464
|
95,540
|
164,533
|
20,979(21)
|
|
506,622
|
|||||||||||||||||||||
| (1) |
We paid the amounts reported for each NEO in New Israeli Shekels. We have translated amounts paid in New Israeli Shekels into U.S. dollars at the foreign exchange rate published by the Bank of Israel as of the date of payment.
|
| (2) |
Represents one time bonuses to Mr. Sella and Mr. Faier in connection with the completion of our initial public offering.
|
| (3) |
The amounts in this column represent the aggregate grant date fair value of the
equity-based
awards granted to our NEOs, computed in accordance with FASB ASC Topic 718. We provide information regarding the assumptions used to calculate the value of the
equity-based
awards in Note 2u to the audited consolidated financial statements included in our Annual Report on Form 10-K filed on February 20, 2018. There can be no assurance that these awards will vest or will be exercised (in which case no value will be realized by the individual), or that the value upon exercise will approximate the aggregate grant date fair value. The values reported in the table for performance-based restricted stock units were calculated assuming that all applicable performance goals would be achieved.
|
| (4) |
Represents the cash bonuses earned pursuant to our Management By Objectives (MBO) program. For more information, see the discussion in the CD&A under the caption Annual Cash Incentive.
|
| (5) |
Includes a $49,996 contribution by the Company to Mr. Sella’s severance fund and $44,265 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation allowance.
|
| (6) |
Includes a $22,835 contribution by the Company to Mr. Sella’s severance fund and $19,966 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation allowance.
|
| (7) |
Includes a $40,250 contribution by the Company to Mr. Sella’s severance fund and $32,185 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation allowance.
|
| (8) |
Includes a $24,833 contribution by the Company to Mr. Sella’s severance fund and $21,916 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation allowance.
|
| (9) |
Includes a $27,404 contribution by the Company to Mr. Faier’s severance fund and $26,321 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation allowance.
|
| (10) |
Includes a $12,674 contribution by the Company to Mr. Faier’s severance fund and $12,257 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation allowance.
|
| (11) |
Includes a $22,772 contribution by the Company to Mr. Faier’s severance fund and $19,894 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation allowance
|
| (12) |
Includes a $15,021 contribution by the Company to Mr. Faier’s severance fund and $13,699 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation allowance.
|
| (13) |
Includes a $28,633 contribution by the Company to Mr. Lando’s severance fund and $27.669 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation allowance.
|
| (14) |
Includes a $13,191 contribution by the Company to Mr. Lando’s severance fund and $12,741 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation allowance.
|
| (15) |
Includes a $24,032 contribution by the Company to Mr. Lando’s severance fund and $22,297 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation allowance.
|
| (16) |
Includes a $15,849 contribution by the Company to Mr. Lando’s severance fund and $15,839 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation allowance.
|
| (17) |
Includes a $26,363 contribution by the Company to Mr. Galin’s severance fund and $25,832 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation allowance.
|
| (18) |
Includes a $12,127 contribution by the Company to Mr. Galin’s severance fund and $12,093 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation allowance.
|
| (19) |
Includes a $21,850 contribution by the Company to Mr. Galin’s severance fund and $20,406 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation allowance.
|
| (20) |
Includes a $22,914 contribution by the Company to Mr. Handelsman’s severance fund and $23,391 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation allowance.
|
| (21) |
Includes a $10,371 contribution by the Company to Mr. Handelsman’s severance fund and $10,607 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation allowance.
|
|
Name
|
Equity Award Grant Date
|
Estimated Future Payouts under Non-Equity Incentive Plan Awards
|
All Other Stock Awards: Number of Shares of Stock or Units
|
All Other Option Awards: Number of Securities Underlying Options
|
Exercise or Base Price of Option Awards ($/Share)
|
Grant Date Fair Value of Stock & Option Awards ($)(1)
|
|||||||||||||||||||
|
Threshold
($)
|
Target
($)(2)
|
Maximum
($)
|
|||||||||||||||||||||||
|
Guy Sella
|
550,000
|
550,000
|
|||||||||||||||||||||||
|
2/14/2017
|
126,207
|
$
|
14.85
|
1,002,437
|
|||||||||||||||||||||
|
2/14/2017
|
68,259
|
986,343
|
|||||||||||||||||||||||
|
Ronen Faier
|
210,000
|
210,000
|
|||||||||||||||||||||||
|
2/14/2017
|
40,948
|
$
|
14.85
|
325,242
|
|||||||||||||||||||||
|
2/14/2017
|
22,146
|
320,010
|
|||||||||||||||||||||||
|
Zvi Lando
|
210,000
|
210,000
|
|||||||||||||||||||||||
|
2/14/2017
|
40,948
|
$
|
14.85
|
325,242
|
|||||||||||||||||||||
|
2/14/2017
|
22,146
|
320,010
|
|||||||||||||||||||||||
|
Yoav Galin
|
193,333
|
193,333
|
|||||||||||||||||||||||
|
2/14/2017
|
40,948
|
$
|
14.85
|
325,242
|
|||||||||||||||||||||
|
2/14/2017
|
22,146
|
320,010
|
|||||||||||||||||||||||
|
Lior Handelsman
|
176,667
|
176,667
|
|||||||||||||||||||||||
|
2/14/2017
|
23,853
|
$
|
14.85
|
189,460
|
|||||||||||||||||||||
|
2/14/2017
|
12,901
|
186,419
|
|||||||||||||||||||||||
| (1) |
The amounts in this column represent the aggregate grant date fair value of the equity based awards granted to our NEOs, computed in accordance with FASB ASC Topic 718. We provide information regarding the assumptions used to calculate the value of these equity based awards in Note 2u to the audited consolidated financial statements included in our Annual Report on Form 10-K filed on February 20, 2018. There can be no assurance that these awards will vest or will be exercised (in which case no value will be realized by the individual), or that the value upon exercise will approximate the aggregate grant date fair value.
|
| (2) |
The Non-Equity Incentive Plan does not include any thresholds or a maximum cap for the Non-Equity Awards
.
|
|
Option Awards
|
Stock Awards
|
|||||||||||||||||||||||
|
Name
|
Number of
Securities Underlying Unexercised Options Exercisable |
Number of
Securities Underlying Unexercised Options Unexercisable |
Option
Exercise Price ($) |
Option
Expiration Date |
Number of
Shares or Units of Stock that have not Vested |
Market
Value of Shares or Units of Stock that have not Vested ($) |
||||||||||||||||||
|
Guy Sella
|
73,333
|
—
|
$
|
1.50
|
July 1, 2019
|
—
|
—
|
|||||||||||||||||
|
76,667
|
—
|
$
|
2.46
|
January 26, 2022
|
—
|
—
|
||||||||||||||||||
|
52,778
|
13,888
|
(1)
|
$
|
5.01
|
October 29, 2024
|
—
|
—
|
|||||||||||||||||
|
582,939
|
194,314
|
(2)
|
$
|
5.01
|
December 22, 2024
|
—
|
—
|
|||||||||||||||||
|
27,000
|
21,000
|
(3)
|
$
|
25.09
|
August 19, 2025
|
—
|
—
|
|||||||||||||||||
|
17,129
|
37,684
|
(4)
|
$
|
17.14
|
August 23, 2026
|
—
|
—
|
|||||||||||||||||
|
23,663
|
102,544
|
(5)
|
$
|
14.85
|
February 14, 2027
|
—
|
—
|
|||||||||||||||||
|
—
|
—
|
—
|
—
|
|
15,750
|
(6)
|
$
|
591,413
|
||||||||||||||||
|
—
|
—
|
—
|
—
|
|
20,056
|
(7)
|
$
|
753,103
|
||||||||||||||||
|
—
|
—
|
—
|
—
|
|
55,041
|
(8)
|
$
|
2,082,561
|
||||||||||||||||
|
Ronen Faier
|
61,666
|
—
|
$
|
2.46
|
January 26, 2022
|
—
|
—
|
|||||||||||||||||
|
52,778
|
13,889
|
(1)
|
$
|
5.01
|
October 29, 2024
|
—
|
—
|
|||||||||||||||||
|
10,800
|
8,400
|
(3)
|
$
|
25.09
|
August 19, 2025
|
—
|
—
|
|||||||||||||||||
|
5,557
|
12,227
|
(4)
|
$
|
17.14
|
August 23, 2026
|
—
|
—
|
|||||||||||||||||
|
7,677
|
33,271
|
(5)
|
$
|
14.85
|
February 14, 2027
|
—
|
—
|
|||||||||||||||||
|
—
|
—
|
—
|
—
|
6,300
|
(6)
|
$
|
236,565
|
|||||||||||||||||
|
—
|
—
|
—
|
—
|
|
6,508
|
(7)
|
$
|
244,375
|
||||||||||||||||
|
—
|
—
|
—
|
—
|
17,994
|
(8)
|
$
|
675,675
|
|||||||||||||||||
|
Zvi Lando
|
8,333
|
—
|
$
|
1.50
|
May 28, 2019
|
—
|
—
|
|||||||||||||||||
|
63,333
|
—
|
$
|
2.01
|
January 25, 2021
|
—
|
—
|
||||||||||||||||||
|
68,333
|
—
|
$
|
2.46
|
January 26, 2022
|
—
|
—
|
||||||||||||||||||
|
52,778
|
13,889
|
(1)
|
$
|
5.01
|
October 29, 2024
|
—
|
—
|
|||||||||||||||||
|
10,800
|
8,400
|
(3)
|
$
|
25.09
|
August 19, 2025
|
—
|
—
|
|||||||||||||||||
|
5,557
|
12,227
|
(4)
|
$
|
17.14
|
August 23, 2026
|
—
|
—
|
|||||||||||||||||
|
7,677
|
33,271
|
(5)
|
$
|
14.85
|
February 14, 2027
|
—
|
—
|
|||||||||||||||||
|
—
|
—
|
—
|
—
|
|
6,300
|
(6)
|
$
|
236,565
|
||||||||||||||||
|
—
|
—
|
—
|
—
|
6,508
|
(7)
|
$
|
244,375
|
|||||||||||||||||
|
—
|
—
|
—
|
—
|
|
17,994
|
(8)
|
$
|
675,675
|
||||||||||||||||
|
Yoav Galin
|
47,778
|
13,888
|
(1)
|
$
|
5.01
|
October 29, 2024
|
—
|
—
|
||||||||||||||||
|
10,800
|
8,400
|
(3)
|
$
|
25.09
|
August 19, 2025
|
—
|
—
|
|||||||||||||||||
|
5,557
|
12,227
|
(4)
|
$
|
17.14
|
August 23, 2026
|
—
|
—
|
|||||||||||||||||
|
7,677
|
33,271
|
(5)
|
$
|
14.85
|
February 14, 2027
|
—
|
—
|
|||||||||||||||||
|
—
|
—
|
—
|
—
|
6,300
|
(6)
|
$
|
236,565
|
|||||||||||||||||
|
—
|
—
|
—
|
—
|
6,508
|
(7)
|
$
|
244,375
|
|||||||||||||||||
|
—
|
—
|
—
|
—
|
17,994
|
(8)
|
$
|
675,675
|
|||||||||||||||||
|
Lior Handelsman
|
73,333
|
—
|
$
|
1.50
|
July 1, 2019
|
—
|
—
|
|||||||||||||||||
|
76,667
|
—
|
$
|
2.46
|
January 26, 2022
|
—
|
—
|
||||||||||||||||||
|
52,778
|
13,888
|
(1)
|
$
|
5.01
|
October 29, 2024
|
—
|
—
|
|||||||||||||||||
|
6,300
|
4,900
|
(3)
|
$
|
25.09
|
August 19, 2025
|
—
|
—
|
|||||||||||||||||
|
3,237
|
7,123
|
(4)
|
$
|
17.14
|
August 23, 2026
|
—
|
—
|
|||||||||||||||||
|
4,472
|
19,381
|
(5)
|
$
|
14.85
|
February 14, 2027
|
—
|
—
|
|||||||||||||||||
|
—
|
—
|
—
|
—
|
3,676
|
(6)
|
$
|
138,034
|
|||||||||||||||||
|
—
|
—
|
—
|
—
|
|
3,791
|
(7)
|
$
|
142,352
|
||||||||||||||||
|
—
|
—
|
—
|
—
|
|
10,483
|
(8)
|
$
|
393,637
|
||||||||||||||||
| (1) |
The shares subject to the stock option vest over a four‑year period commencing October 31, 2014, with 1/48 of the shares vesting monthly thereafter.
|
| (2) |
The shares subject to the stock option vest over a four‑year period commencing December 31, 2014, with 1/48 of the shares vesting monthly thereafter.
|
| (3) |
The shares subject to the stock option vest over a four‑year period commencing August 31, 2015, with 1/16 of the shares vesting quarterly thereafter.
|
| (4) |
The shares subject to the stock option vest over a four‑year period commencing August 31, 2016, with 1/16 of the shares vesting quarterly thereafter.
|
| (5) |
The shares subject to the stock option vest over a four‑year period commencing February 28, 2017, with 1/16 of the shares vesting quarterly thereafter.
|
| (6) |
The shares subject to the RSU vest over a four-year period commencing on August 31, 2015, with 1/16 of the shares vesting quarterly thereafter.
|
| (7) |
The shares subject to the RSU vest over a four-year period commencing on August 31, 2016, with 1/16 of the shares vesting quarterly thereafter.
|
| (8) |
The shares subject to the RSU vest over a four-year period commencing on February 28, 2017, with 1/16 of the shares vesting quarterly thereafter.
|
|
Option Awards
|
Stock Awards
|
|||||||||||||||
|
Name
|
Number of Shares Acquired on Exercise
|
Value Realized upon Exercise
($)(1)
|
Number of Shares
Acquired on Vesting |
Value Realized on
Vesting ($)(2) |
||||||||||||
|
Guy Sella
|
-
|
-
|
29,091
|
$
|
741,409
|
|||||||||||
|
Ronen Faier
|
130,000
|
$
|
3,803,419
|
10,118
|
$
|
256,916
|
||||||||||
|
Zvi Lando
|
90,000
|
$
|
2,497,483
|
10,118
|
$
|
256,916
|
||||||||||
|
Yoav Galin
|
80,000
|
$
|
2,285,390
|
10,118
|
$
|
256,916
|
||||||||||
|
Lior Handelsman
|
-
|
-
|
5,896
|
$
|
149,690
|
|||||||||||
|
Name: Guy Sella
|
Termination
upon Death
of Employee
|
Termination
for Cause
|
Voluntary
Termination
by Employee
After
Provision of
Requisite
Notice
|
Termination
by Company
After
Provision of
Requisite
Notice
|
Termination
w/o Cause or
for Good Reason
|
Termination
w/o Cause or
for Good
Reason within
12 months of
Change in
Control
|
||||||||||||||||||
|
Base Salary
|
-
|
-
|
154,673
|
154,673
|
154,673
|
154,673
|
||||||||||||||||||
|
Israeli Social Benefits
|
-
|
-
|
24,373
|
24,373
|
24,373
|
24,373
|
||||||||||||||||||
|
Unvested Options/RSUs (1)
|
-
|
-
|
2,315,794
|
2,315,794
|
2,315,794
|
13,560,508
|
||||||||||||||||||
|
Accrued Vacation Pay
|
404,966
|
404,966
|
404,966
|
404,966
|
404,966
|
404,966
|
||||||||||||||||||
|
TOTAL
|
404,966
|
404,966
|
2,899,806
|
2,899,806
|
2,899,806
|
14,144,520
|
||||||||||||||||||
| (1) |
The value realized is based on the difference between the exercise price of the stock options and the closing price of our common stock on the last trading day of the
year ended December 31, 2017,
and, in the case of RSUs, the number of RSUs that would have vested multiplied by the closing price of our common stock on the last trading day of the
year ended December 31, 2017
.
|
|
Name: Ronen Faier
|
Termination
upon Death
of Employee
|
Termination
for Cause
|
Voluntary
Termination
by Employee
After
Provision of
Requisite
Notice
|
Termination
by Company
After
Provision of
Requisite
Notice
|
Termination
w/o Cause or
for Good Reason
|
Termination
w/o Cause or
for Good
Reason within
12 months of
Change in
Control
|
||||||||||||||||||
|
Base Salary
|
-
|
-
|
59,057
|
59,057
|
59,057
|
59,057
|
||||||||||||||||||
|
Israeli Social Benefits
|
-
|
-
|
9,128
|
9,128
|
9,128
|
9,128
|
||||||||||||||||||
|
Unvested Options/RSUs (1)
|
-
|
-
|
294,117
|
294,117
|
294,117
|
2,718,032
|
||||||||||||||||||
|
Accrued Vacation Pay
|
95,823
|
95,823
|
95,823
|
95,823
|
95,823
|
95,823
|
||||||||||||||||||
|
TOTAL
|
95,823
|
95,823
|
458,125
|
458,125
|
458,125
|
2,882,040
|
||||||||||||||||||
| (1) |
The value realized is based on the difference between the exercise price of the stock options and the closing price of our common stock on the last trading day of the
year ended December 31, 2017,
and, in the case of RSUs, the number of RSUs that would have vested multiplied by the closing price of our common stock on the last trading day of the
year ended December 31, 2017
.
|
|
Name: Zvi Lando
|
Termination
upon Death
of Employee
|
Termination
for Cause
|
Voluntary
Termination
by Employee
After
Provision of
Requisite
Notice
|
Termination
by Company
After
Provision of
Requisite
Notice
|
Termination
w/o Cause or
for Good Reason
|
Termination
w/o Cause within
12 months of
Change in
Control(2)
|
||||||||||||||||||
|
Base Salary
|
-
|
-
|
59,057
|
59,057
|
59,057
|
59,057
|
||||||||||||||||||
|
Israeli Social Benefits
|
-
|
-
|
9,597
|
9,597
|
9,597
|
9,597
|
||||||||||||||||||
|
Unvested Options/RSUs (1)
|
-
|
-
|
294,117
|
294,117
|
294,117
|
2,718,032
|
||||||||||||||||||
|
Accrued Vacation Pay
|
148,882
|
148,882
|
148,882
|
148,882
|
148,882
|
148,882
|
||||||||||||||||||
|
TOTAL
|
148,882
|
148,882
|
511,653
|
511,653
|
511,653
|
2,935,568
|
||||||||||||||||||
| (1) |
The value realized is based on the difference between the exercise price of the stock options and the closing price of our common stock on the last trading day of the
year ended December 31, 2017,
and, in the case of RSUs, the number of RSUs that would have vested multiplied by the closing price of our common stock on the last trading day of the
year ended December 31, 2017
.
|
|
Name: Yoav Galin
|
Termination
upon Death
of Employee
|
Termination
for Cause
|
Voluntary
Termination
by Employee
After
Provision of
Requisite
Notice
|
Termination
by Company
After
Provision of
Requisite
Notice
|
Termination
w/o Cause or
for Good Reason
|
Termination
w/o Cause or
for Good
Reason within
12 months of
Change in
Control
|
||||||||||||||||||
|
Base Salary
|
-
|
-
|
81,555
|
81,555
|
81,555
|
81,555
|
||||||||||||||||||
|
Israeli Social Benefits
|
-
|
-
|
13,233
|
13,233
|
13,233
|
13,233
|
||||||||||||||||||
|
Unvested Options/RSUs (1)
|
-
|
-
|
339,315
|
339,315
|
339,315
|
2,717,999
|
||||||||||||||||||
|
Accrued Vacation Pay
|
319,206
|
319,206
|
319,206
|
319,206
|
319,206
|
319,206
|
||||||||||||||||||
|
TOTAL
|
319,206
|
319,206
|
753,309
|
753,309
|
753,309
|
3,131,993
|
||||||||||||||||||
| (1) |
The value realized is based on the difference between the exercise price of the stock options and the closing price of our common stock on the last trading day of the
year ended December 31, 2017,
and, in the case of RSUs, the number of RSUs that would have vested multiplied by the closing price of our common stock on the last trading day of the
year ended December 31, 2017
.
|
|
Name: Lior Handelsman
|
Termination
upon Death
of Employee
|
Termination
for Cause
|
Voluntary
Termination
by Employee
After
Provision of
Requisite
Notice
|
Termination
by Company
After
Provision of
Requisite
Notice
|
Termination
w/o Cause or
for Good Reason
|
Termination
w/o Cause or
for Good
Reason within
12 months of
Change in
Control
|
||||||||||||||||||
|
Base Salary
|
-
|
-
|
74,524
|
74,524
|
74,524
|
74,524
|
||||||||||||||||||
|
Israeli Social Benefits
|
-
|
-
|
11,753
|
11,753
|
11,753
|
11,753
|
||||||||||||||||||
|
Unvested Options/RSUs (1)
|
-
|
-
|
254,364
|
254,364
|
254,364
|
1,772,321
|
||||||||||||||||||
|
Accrued Vacation Pay
|
157,613
|
157,613
|
157,613
|
157,613
|
157,613
|
157,613
|
||||||||||||||||||
|
TOTAL
|
157,613
|
157,613
|
498,254
|
498,254
|
498,254
|
2,016,211
|
||||||||||||||||||
| (1) |
The value realized is based on the difference between the exercise price of the stock options or the base price of the stock appreciation rights and the closing price of our common stock on the last trading day of the Stub Period and, in the case of RSUs, the number of RSUs that would have vested multiplied by the closing price of our common stock on the last trading day of the Stub Period.
|
|
Position
|
Retainer ($)
|
|||
|
Board Member
|
50,000
|
|||
|
Audit Committee Chair
|
25,000
|
|||
|
Compensation Committee Chair
|
17,500
|
|||
|
Nominating and Corporate Governance Committee Chair
|
10,000
|
|||
|
Audit Committee Member
|
10,000
|
|||
|
Compensation Committee Member
|
7,500
|
|||
|
Nominating and Corporate Governance Committee Member
|
5,000
|
|||
|
Name
|
Fees Earned or Paid in Cash ($)
|
Stock Awards ($) (1)
|
Option Awards ($)
|
Non-Equity Incentive Plan Compensation ($)
|
Nonqualified Deferred Compensation Earnings ($)
|
All Other Compensation ($)
|
Total ($)
|
|||||||||||||||||||||
|
Dan Avida (2)
|
55,000
|
100,000
|
—
|
—
|
—
|
—
|
155,000
|
|||||||||||||||||||||
|
Yoni Cheifetz
|
-
|
100,000
|
—
|
—
|
—
|
—
|
100,000
|
|||||||||||||||||||||
|
Marcel Gani
|
71,250
|
100,000
|
—
|
—
|
—
|
—
|
171,250
|
|||||||||||||||||||||
|
Doron Inbar
|
58,125
|
100,000
|
—
|
—
|
—
|
—
|
158,125
|
|||||||||||||||||||||
|
Avery More
|
68,125
|
100,000
|
—
|
—
|
—
|
—
|
168,125
|
|||||||||||||||||||||
|
Tal Payne
|
52,500
|
100,000
|
—
|
—
|
—
|
—
|
152,500
|
|||||||||||||||||||||
| (1) |
Represents the grant date fair value of 5,618 restricted stock units granted to each director on May 11, 2017, calculated in accordance with U.S. GAAP. All units will become fully vested on May 10, 2018. The grant date fair value is based on $17.80 per share, the closing price of our share on the grant date. As of December 31, 2017, each director held 5,618 unvested restricted stock units.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|